Caprelsa tablets 100mg (Vandetanib) from Sanofi, YJ code 4291041F1029 (100mg 1 tablet), is an antineoplastic kinase inhibitor used to treat symptomatic or progressive medullary thyroid cancer that is unresectable, locally advanced, or metastatic.
Caprelsa tablets 100mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →